Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve the un-audited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited has informed BSE that its Board of Directors will meet on Wednesday, August 13, 2025, at 2:00 PM at its corporate office in Andheri (West), Mumbai. The primary agenda is to consider and approve the un-audited financial results under Ind-AS for the quarter ended June 30, 2025 (Q1 FY26). The company will intimate the results to the exchanges after the meeting and will also publish them on its website and in the press. The notice was signed by Nishant Kankaria, Company Secretary & Compliance Officer, on June 23, 2025.
This is a routine regulatory filing with no material impact on shareholders. Investors should watch for the actual Q1 results on or after August 13, 2025, to assess the company's performance for the first quarter of FY26.